Not only were MEF2A, MEF2C and MEF2D mRNAs detected in DLBCL patient samples using RNA-seq14, they were more abundant than MEF2B mRNA (Supplementary Fig. 26a). This evidence concerns the gene MEF2D and diffuse large B-cell lymphoma.